Matches in Wikidata for { <http://www.wikidata.org/entity/Q37226025> ?p ?o ?g. }
- Q37226025 description "article científic" @default.
- Q37226025 description "article scientifique" @default.
- Q37226025 description "articolo scientifico" @default.
- Q37226025 description "artigo científico" @default.
- Q37226025 description "artículu científicu espublizáu en 2015" @default.
- Q37226025 description "bilimsel makale" @default.
- Q37226025 description "scientific article published on December 2015" @default.
- Q37226025 description "vedecký článok" @default.
- Q37226025 description "vetenskaplig artikel" @default.
- Q37226025 description "videnskabelig artikel" @default.
- Q37226025 description "vědecký článek" @default.
- Q37226025 description "wetenschappelijk artikel" @default.
- Q37226025 description "wissenschaftlicher Artikel" @default.
- Q37226025 description "наукова стаття, опублікована в грудні 2015" @default.
- Q37226025 description "научни чланак" @default.
- Q37226025 description "مقالة علمية نشرت في ديسمبر 2015" @default.
- Q37226025 name "The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China" @default.
- Q37226025 name "The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China" @default.
- Q37226025 name "The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China" @default.
- Q37226025 type Item @default.
- Q37226025 label "The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China" @default.
- Q37226025 label "The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China" @default.
- Q37226025 label "The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China" @default.
- Q37226025 prefLabel "The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China" @default.
- Q37226025 prefLabel "The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China" @default.
- Q37226025 prefLabel "The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China" @default.
- Q37226025 P1433 Q37226025-5BB3E8F0-FF1E-4FF1-A694-D098859D903E @default.
- Q37226025 P1476 Q37226025-73F3840D-58ED-465A-B113-16263FF71E16 @default.
- Q37226025 P2093 Q37226025-0476BE0C-6BEB-4408-A5BA-7F6DAFD2239B @default.
- Q37226025 P2093 Q37226025-27C78E4F-989C-4055-AD90-683ED2F1AE87 @default.
- Q37226025 P2093 Q37226025-3F68E25E-97CC-4F7C-951E-E88B7206A10C @default.
- Q37226025 P2093 Q37226025-41B753CF-C317-4B40-B219-6C59787262A5 @default.
- Q37226025 P2093 Q37226025-532A5C4F-8309-4F62-8969-E0EBFBCB3D81 @default.
- Q37226025 P2093 Q37226025-55B1C59A-B017-4D9B-8A3D-34D047B65887 @default.
- Q37226025 P2093 Q37226025-5A31545D-3AAB-4DDA-94D1-0C7EECEA19FE @default.
- Q37226025 P2093 Q37226025-83D45E28-CB28-42A0-A3A4-44FF978BE3F2 @default.
- Q37226025 P2093 Q37226025-AA5528E1-A515-43E8-B594-388C6269E95B @default.
- Q37226025 P2093 Q37226025-B62FDBBC-E4CE-405E-BB0E-1EAC825E74FB @default.
- Q37226025 P2093 Q37226025-D6AF5B18-147E-490C-AD24-2171351B7927 @default.
- Q37226025 P2093 Q37226025-F41AB8E4-F9B4-4958-B9C2-41AA78BCB26E @default.
- Q37226025 P2093 Q37226025-FB227637-1F87-4954-83F3-2148DF8AB6DF @default.
- Q37226025 P2093 Q37226025-FB3BA830-9EA7-4471-A1C6-320594A252D4 @default.
- Q37226025 P2860 Q37226025-081E6D72-4C40-4CDC-A1F6-74E5C01EF59B @default.
- Q37226025 P2860 Q37226025-1BEFB092-5B27-48D1-85EE-1EBA0E9724FD @default.
- Q37226025 P2860 Q37226025-291D4E50-F0AB-4388-BF07-4B3E241D0245 @default.
- Q37226025 P2860 Q37226025-2A4BDB3F-645C-4CB5-AE05-3B29D7D5E505 @default.
- Q37226025 P2860 Q37226025-2E928DA2-C580-4515-9838-7F698FF0DB1A @default.
- Q37226025 P2860 Q37226025-42F7C70F-4CB5-40FD-8270-D6D9EF910B0E @default.
- Q37226025 P2860 Q37226025-47F0AE26-607B-4374-A92A-33048C994132 @default.
- Q37226025 P2860 Q37226025-4CEB3251-2D3B-4FB9-B973-68A9CF4515CE @default.
- Q37226025 P2860 Q37226025-4E7292C0-2BBA-4E51-881E-8F1FFBCC8DAF @default.
- Q37226025 P2860 Q37226025-5C2F6D15-48A9-4933-969A-0E8014A2CC97 @default.
- Q37226025 P2860 Q37226025-6659DA19-21D4-4DB8-BC9A-0E830C9A76AF @default.
- Q37226025 P2860 Q37226025-81E1A697-5580-4921-BBEA-B3549DEF99DC @default.
- Q37226025 P2860 Q37226025-886ACEE6-FE21-42AE-9C49-20E705BF561F @default.
- Q37226025 P2860 Q37226025-88F5D652-9E9A-4448-B1D4-645CD410FA3B @default.
- Q37226025 P2860 Q37226025-95FD2A19-6CA3-4AD5-A8CE-A223CBB7F94D @default.
- Q37226025 P2860 Q37226025-98639A52-9FFF-47D8-951E-256ECE5E53EF @default.
- Q37226025 P2860 Q37226025-9A1718BC-1194-4375-960F-6E5CA5D52276 @default.
- Q37226025 P2860 Q37226025-B27CF818-1C68-40F7-AD1A-CA91A4C36865 @default.
- Q37226025 P2860 Q37226025-B3124C12-BEE0-4EAF-AAC8-80D1F591787C @default.
- Q37226025 P2860 Q37226025-C22C0776-42F5-4949-9843-E5A34F4FB321 @default.
- Q37226025 P2860 Q37226025-C3DFA3B8-04A0-4068-914A-F33638C3734F @default.
- Q37226025 P2860 Q37226025-C73DC39F-992C-469F-BDC0-46565516C0AA @default.
- Q37226025 P2860 Q37226025-CA2CE6AC-00F9-41CF-A943-69B29E506443 @default.
- Q37226025 P2860 Q37226025-CCC357FB-AFC7-49C9-A19E-0EE8DEFF1B86 @default.
- Q37226025 P2860 Q37226025-E2EDD9DD-A201-468A-90E5-4BE38162D303 @default.
- Q37226025 P2860 Q37226025-E62137BA-F23E-4F2D-96B2-3E1A61059BCD @default.
- Q37226025 P2860 Q37226025-E6D5E1AA-5F80-4D74-B5FF-078851B217F1 @default.
- Q37226025 P2860 Q37226025-F0F217C5-34A5-43D7-860F-4DFD97ED4601 @default.
- Q37226025 P2860 Q37226025-FBC0468B-6726-4232-BB14-88F43CA4759B @default.
- Q37226025 P304 Q37226025-3DB99116-BCE0-49AC-BD01-FABFE3EF52DE @default.
- Q37226025 P31 Q37226025-2F7478B6-0C54-412F-BACB-4DFC97E853FA @default.
- Q37226025 P356 Q37226025-5C505B84-D293-452F-BE75-DE0905D7CA39 @default.
- Q37226025 P407 Q37226025-7361FF7D-E1B8-483C-BC44-D721B737ACFA @default.
- Q37226025 P433 Q37226025-A11F02AE-45FF-45BD-9D1E-657B358DBCE0 @default.
- Q37226025 P478 Q37226025-A57016F1-2431-41DA-ADC9-98355B76FE39 @default.
- Q37226025 P577 Q37226025-5B2BCB9F-BCDF-425C-B17A-7D99B296568F @default.
- Q37226025 P698 Q37226025-C72DFF79-6850-48FA-B3E1-F276A39CE317 @default.
- Q37226025 P921 Q37226025-656FB0B1-85BB-410E-956E-1EF221E89468 @default.
- Q37226025 P921 Q37226025-D91FC603-AA3E-4B1B-B1C4-23C686D3C78C @default.
- Q37226025 P921 Q37226025-EB326F2F-6E88-42C3-B158-83C7716AD970 @default.
- Q37226025 P932 Q37226025-1F280890-84B6-47BE-804F-FAFBB9B739B9 @default.
- Q37226025 P356 MD.0000000000002222 @default.
- Q37226025 P698 26656362 @default.
- Q37226025 P1433 Q15716652 @default.
- Q37226025 P1476 "The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study from Northwest China" @default.
- Q37226025 P2093 "Fuli Wang" @default.
- Q37226025 P2093 "Guojun Wu" @default.
- Q37226025 P2093 "Jian Wang" @default.
- Q37226025 P2093 "Jianlin Yuan" @default.
- Q37226025 P2093 "Jingyi Lu" @default.
- Q37226025 P2093 "Longlong Zhang" @default.
- Q37226025 P2093 "Peijun Li" @default.
- Q37226025 P2093 "Peng Chen" @default.
- Q37226025 P2093 "Qing Wang" @default.
- Q37226025 P2093 "Xitao Lu" @default.
- Q37226025 P2093 "Yangmin Wang" @default.
- Q37226025 P2093 "Yu Zheng" @default.
- Q37226025 P2093 "Yujie Wang" @default.